BETADINA
BETADINA is a medicine authorised by Swissmedic under authorisation number 68390. The authorisation holder is iNova Pharmaceuticals (Switzerland) AG. The medicinal product code is Synthetic medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 27 April 2021 and the authorisation is valid without a time limit. The export lists no ATC code for this medicine.
| Authorisation number | 68390 |
|---|---|
| Name | BETADINA |
| Full name | BETADINA, desinfizierendes Gurgelkonzentrat |
| Authorisation holder | iNova Pharmaceuticals (Switzerland) AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | D · No prescription, with advice |
| ATC code | not stated |
| First authorisation | 27 April 2021 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | BETADINA, desinfizierendes Gurgelkonzentrat | D | 27 April 2021 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| The Swissmedic export lists no pack sizes for this medicine. | |||||
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is BETADINA authorised in Switzerland?
Yes. BETADINA is authorised by Swissmedic under authorisation number 68390, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does BETADINA have?
BETADINA is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.
Who is the authorisation holder of BETADINA?
The authorisation holder is iNova Pharmaceuticals (Switzerland) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.